Skip to main content
Journal of Clinical Microbiology logoLink to Journal of Clinical Microbiology
. 1992 Aug;30(8):2029–2032. doi: 10.1128/jcm.30.8.2029-2032.1992

Development of revised quality control limits for disk diffusion susceptibility tests of selected cephem antibiotics with Haemophilus influenzae and description of a new control strain.

J H Jorgensen 1, A L Barry 1, G V Doern 1, M J Ferraro 1, P R Murray 1
PMCID: PMC265436  PMID: 1500510

Abstract

Inconsistent quality control results in disk diffusion testing of cefaclor, cefamandole, cefonicid, and cefuroxime with Haemophilus influenzae ATCC 49247 and Haemophilus test medium (HTM) prompted a search for an alternative control strain that would provide more reliable results. A five-laboratory study was conducted to evaluate two candidate H. influenzae strains as possible alternatives to the aforementioned strain. Repetitive testing of the candidate strains and H. influenzae ATCC 49247 over several days with a total of six different lots of HTM documented consistent performance of the two candidate strains and confirmed inconsistent results for some of the antibiotics with H. influenzae ATCC 49247. In particular, certain lots of HTM failed to yield cefaclor and cefamandole zone sizes within the quality control range advocated by the National Committee for Clinical Laboratory Standards. Because of the greater consistency offered by the new strains, one was selected (now designated H. influenzae ATCC 49766) to be recommended for routine quality control testing of cefaclor, cefamandole, cefonicid, cefuroxime, and the related carbacephem loracarbef. The new control strain and zone size ranges proposed here have been approved by the National Committee for Clinical Laboratory Standards in place of the previously recommended strain and zone size limits for testing of these five cephem antibiotics.

Full text

PDF
2029

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Barry A. L., Packer R. R. Performance of Haemophilus Test Media prepared with 12 different lots of Mueller-Hinton agar from four manufacturers. J Clin Microbiol. 1992 May;30(5):1145–1147. doi: 10.1128/jcm.30.5.1145-1147.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Doern G. V., Gerlach E. H., Jorgensen J. H., Murray P. R., Thornsberry C., Washington J. A., Jr Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn Microbiol Infect Dis. 1991 Nov-Dec;14(6):485–493. doi: 10.1016/0732-8893(91)90004-y. [DOI] [PubMed] [Google Scholar]
  3. Gavan T. L., Jones R. N., Barry A. L., Fuchs P. C., Gerlach E. H., Matsen J. M., Reller L. B., Thornsberry C., Thrupp L. D. Quality control limits for ampicillin, carbenicillin, mezlocillin, and piperacillin disk diffusion susceptibility tests: a collaborative study. J Clin Microbiol. 1981 Jul;14(1):67–72. doi: 10.1128/jcm.14.1.67-72.1981. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Hindler J. A., Inderlied C. B. Effect of the source of Mueller-Hinton agar and resistance frequency on the detection of methicillin-resistant Staphylococcus aureus. J Clin Microbiol. 1985 Feb;21(2):205–210. doi: 10.1128/jcm.21.2.205-210.1985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Hindler J. A., Warner N. L. Effect of source of Mueller-Hinton agar on detection of oxacillin resistance in Staphylococcus aureus using a screening methodology. J Clin Microbiol. 1987 Apr;25(4):734–735. doi: 10.1128/jcm.25.4.734-735.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Jorgensen J. H., Redding J. S., Maher L. A., Howell A. W. Improved medium for antimicrobial susceptibility testing of Haemophilus influenzae. J Clin Microbiol. 1987 Nov;25(11):2105–2113. doi: 10.1128/jcm.25.11.2105-2113.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Knapp C. C., Washington J. A., 2nd In vitro activities of LY163892, cefaclor, and cefuroxime. Antimicrob Agents Chemother. 1988 Jan;32(1):131–133. doi: 10.1128/aac.32.1.131. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Mendelman P. M., Chaffin D. O., Clausen C., Stull T. L., Needham C., Williams J. D., Smith A. L. Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother. 1986 Aug;30(2):274–280. doi: 10.1128/aac.30.2.274. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Mendelman P. M., Chaffin D. O., Stull T. L., Rubens C. E., Mack K. D., Smith A. L. Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother. 1984 Aug;26(2):235–244. doi: 10.1128/aac.26.2.235. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Mendelman P. M., Wiley E. A., Stull T. L., Clausen C., Chaffin D. O., Onay O. Problems with current recommendations for susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother. 1990 Aug;34(8):1480–1484. doi: 10.1128/aac.34.8.1480. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES